BioCentury | Apr 15, 2017
Finance

Formation focus

...raised $82.7 million in three venture rounds from a syndicate that included Novo A/S , HBM BioCapital...
BioCentury | Dec 14, 2015
Financial News

Allena Pharmaceuticals completes venture financing

...Type: Venture financing Raised: $53 million Investors: Partner Fund Management; Fidelity; Wellington Management; Frazier Healthcare; HBM BioCapital...
BioCentury | Dec 10, 2015
Financial News

Allena's series C round brings $53M

...Management. New investors Fidelity and Wellington Management also participated, along with existing investors Frazier Healthcare, HBM BioCapital...
BioCentury | Dec 8, 2014
Financial News

Allena Pharmaceuticals completes venture financing

...Newton, Mass. Business: Endocrine/Metabolic Date completed: 2014-12-04 Type: Venture financing Raised: $25 million Investors: HBM BioCapital...
BioCentury | Jun 3, 2013
Financial News

Ophthotech completes venture financing

...N.Y. Business: Ophthalmic Date completed: 5/29/13 Type: Venture financing Raised: $16.7 million Investors: Novo A/S; HBM BioCapital...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

...Partners Israel $222 Mar-12 Index Ventures Life Sciences Fund U.K.; Switzerland $197 Feb-12 HBM Partners HBM BioCapital...
BioCentury | Jun 11, 2012
Finance

Tending the stable

...and II. HBM BioCapital II had a first close of €90 million ($94.2 million) in February. HBM BioCapital...
BioCentury | Feb 20, 2012
Financial News

HBM Partners financial update

...HBM Partners completed a €90 million ($117.6 million) first close of its HBM BioCapital II fund that...
BioCentury | Feb 14, 2012
Financial News

HBM raises EUR 90M for new fund

...HBM Partners raised EUR 90 million ($117.6 million) in the first close of its HBM BioCapital II...
BioCentury | Feb 13, 2012
Finance

The allure of revenues

...life sciences companies. The firm expects a final close of €120-€150 million ($156.8-$196 million) for HBM BioCapital...
Items per page:
1 - 10 of 33
BioCentury | Apr 15, 2017
Finance

Formation focus

...raised $82.7 million in three venture rounds from a syndicate that included Novo A/S , HBM BioCapital...
BioCentury | Dec 14, 2015
Financial News

Allena Pharmaceuticals completes venture financing

...Type: Venture financing Raised: $53 million Investors: Partner Fund Management; Fidelity; Wellington Management; Frazier Healthcare; HBM BioCapital...
BioCentury | Dec 10, 2015
Financial News

Allena's series C round brings $53M

...Management. New investors Fidelity and Wellington Management also participated, along with existing investors Frazier Healthcare, HBM BioCapital...
BioCentury | Dec 8, 2014
Financial News

Allena Pharmaceuticals completes venture financing

...Newton, Mass. Business: Endocrine/Metabolic Date completed: 2014-12-04 Type: Venture financing Raised: $25 million Investors: HBM BioCapital...
BioCentury | Jun 3, 2013
Financial News

Ophthotech completes venture financing

...N.Y. Business: Ophthalmic Date completed: 5/29/13 Type: Venture financing Raised: $16.7 million Investors: Novo A/S; HBM BioCapital...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

...Partners Israel $222 Mar-12 Index Ventures Life Sciences Fund U.K.; Switzerland $197 Feb-12 HBM Partners HBM BioCapital...
BioCentury | Jun 11, 2012
Finance

Tending the stable

...and II. HBM BioCapital II had a first close of €90 million ($94.2 million) in February. HBM BioCapital...
BioCentury | Feb 20, 2012
Financial News

HBM Partners financial update

...HBM Partners completed a €90 million ($117.6 million) first close of its HBM BioCapital II fund that...
BioCentury | Feb 14, 2012
Financial News

HBM raises EUR 90M for new fund

...HBM Partners raised EUR 90 million ($117.6 million) in the first close of its HBM BioCapital II...
BioCentury | Feb 13, 2012
Finance

The allure of revenues

...life sciences companies. The firm expects a final close of €120-€150 million ($156.8-$196 million) for HBM BioCapital...
Items per page:
1 - 10 of 33